Previous
Next

A Vertically Integrated Latin American Cannabis Company with Global Growth

Khiron Life Sciences Expands to Second Latin America Cultivation Jurisdiction on Closing of Agreement with Dayacann to Enter Chilean Medical Cannabis Market

Khiron Life Sciences Signs Binding LOI to Acquire 100% of NettaGrowth, Securing the First Medical THC and CBD Cannabis Licence and Cultivation Capacity in Uruguay, and Entry to the Brazilian Market

Latest Financial Results

FY 2018

Fiscal Year Ended Dec 31, 2018

Stock Information

Company Overview

Khiron Life Sciences is a Latin American Cannabis Company with Global Growth with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in LatAm.

Investor Presentation

Investor Presentation

Download Investor Presentation

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada

Investor Relations

Chris Naprawa
President
T: +1 416-705-1144
investors@khiron.ca

GRIT Capital
Nicole Marchand
T: 416-428-3533
nmarchand@gritcapital.ca

Transfer Agent

TSX Trust Company
www.tsxtrust.com

Media Contact

Jon Packer
Vice President, Communications
T: +1 416-543-9179
jpacker@khiron.ca

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign up today